drugset / Trial / NCT00127179

A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)

NCT00127179

Phase 3 Completed 600 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with benign prostatic hyperplasia.

Timeline

Start
2004-01-01
Primary completion
2005-07-01
Completion
2005-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Finasteride Small molecule
Subject MK0906 Unknown